These discoveries opened an avenue of preclinical research revealing the anti-inflammatory efficacy of vagus nerve stimulation (VNS) and α7nAChR agonists in endotoxemia, sepsis and many other inflammatory conditions [12, 13]. Here, CHRNA7 is linked to serum lipopolysaccharide activity.